| # | % | |||||
|---|---|---|---|---|---|---|
| 301 | Allergan plc | 12,877 | 2,179,000 | 1.31% | ||
| 302 | JOHNSON & JOHNSON | 21,037 | 2,201,000 | 1.32% | ||
| 303 | JPMORGAN CHASE & CO | 38,969 | 2,245,000 | 1.35% | ||
| 304 | ACCENTURE PLC IRELAND | 28,818 | 2,330,000 | 1.40% | ||
| 305 | ABBOTT LABS | 71,412 | 2,921,000 | 1.75% | ||
| 306 | SILCHESTER INTL INV | 37,894 | 4,213,000 | 2.53% | ||
| 307 | PIMCO UNCONSTRAINED BD FD INST | 467,146 | 5,283,000 | 3.17% | ||
| 308 | Goldman Sachs Satellite Strategies Ptf, Insti | 628,597 | 5,406,000 | 3.25% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000759458-14-000008, filed 2014.07.31).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
